Lifecore Biomedical (LFCR) News Today → The Presidential candidate you should REALLY be worried about (From Stansberry Research) (Ad) Free LFCR Stock Alerts $5.87 +0.10 (+1.73%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 4:45 PM | globenewswire.comLifecore Biomedical Completes Incremental Liquidity InitiativesMay 16 at 3:22 AM | americanbankingnews.comLifecore Biomedical (NASDAQ:LFCR) Stock Price Down 2.1%May 16 at 3:21 AM | marketbeat.comLifecore Biomedical (NASDAQ:LFCR) Shares Down 2.1% Lifecore Biomedical (NASDAQ:LFCR) Shares Down 2.1%May 15 at 10:29 AM | morningstar.comLifecore Biomedical Inc LFCRMay 13, 2024 | prnewswire.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCMay 5, 2024 | prnewswire.comROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCMay 3, 2024 | insidermonkey.comHere’s Why Laughing Water Capital Invested in Lifecore Biomedical (LFCR)April 29, 2024 | prnewswire.comROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCApril 20, 2024 | seekingalpha.comWhite Falcon Capital - Lifecore Biomedical: Potential For Rapid Growth In Earnings And FCF SurgeApril 20, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCRApril 19, 2024 | prnewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCApril 19, 2024 | msn.comLifecore Biomedical gets Nasdaq notice regarding delayed quarterly reportApril 19, 2024 | globenewswire.comLifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly ReportApril 17, 2024 | msn.comLifecore Biomedical (LFCR) Price Target Decreased by 11.11% to 8.16April 12, 2024 | prnewswire.comLFCR INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCRApril 11, 2024 | businesswire.comROSEN, A TOP RANKED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDCApril 11, 2024 | finance.yahoo.comDo You Believe in the Upside Trajectory of Lifecore Biomedical (LFCR)?April 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCRApril 1, 2024 | finance.yahoo.comLifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date ProgressMarch 28, 2024 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of InvestorsMarch 28, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of InvestorsMarch 28, 2024 | businesswire.comLifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsMarch 28, 2024 | finanznachrichten.deLifecore Biomedical, Inc.: Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business UpdateMarch 26, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Announces Investigation of Lifecore Biomedical, Inc. (LFCR) on Behalf of InvestorsMarch 26, 2024 | globenewswire.comLifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business UpdateMarch 24, 2024 | stockhouse.comLifecore Class Action Lawsuit Investigation News - Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLPMarch 24, 2024 | businesswire.comLifecore Class Action Lawsuit Investigation News – Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLPMarch 21, 2024 | businesswire.comLifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsMarch 21, 2024 | businesswire.comKirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR)March 21, 2024 | marketwatch.comLifecore Shares Slide After Strategic Review Ends With No DealMarch 20, 2024 | msn.comWhy Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionMarch 20, 2024 | finanznachrichten.deLifecore Biomedical, Inc.: Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023March 20, 2024 | markets.businessinsider.comLifecore Biomedical: Board Concludes Review; To Execute Strategic Plan As Standalone CompanyMarch 20, 2024 | msn.comLifecore Biomedical concludes strategic evaluation process, names new CEOMarch 20, 2024 | globenewswire.comLifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board ChangesMarch 20, 2024 | globenewswire.comLifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023March 16, 2024 | finance.yahoo.comLFCR Apr 2024 7.500 callMarch 13, 2024 | marketbeat.comLifecore Biomedical, Inc. (NASDAQ:LFCR) is Greenhaven Road Investment Management L.P.'s 6th Largest PositionGreenhaven Road Investment Management L.P. raised its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 15.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,193,333 shares of the cFebruary 17, 2024 | finance.yahoo.comLFCR Mar 2024 10.000 callFebruary 17, 2024 | finance.yahoo.comLFCR Mar 2024 10.000 putFebruary 16, 2024 | msn.comLifecore Biomedical receives Nasdaq notice of delistingFebruary 16, 2024 | finance.yahoo.comLifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to AppealFebruary 16, 2024 | globenewswire.comLifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to AppealFebruary 13, 2024 | marketbeat.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Sold by HAP Trading LLCHAP Trading LLC lessened its holdings in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 82.6% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 163,773 shares of the company's stock after selling 775,527 sharFebruary 12, 2024 | marketbeat.comCove Street Capital LLC Sells 513,980 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR)Cove Street Capital LLC reduced its stake in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 31.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,105,556 shares of the company's stock after selling 513,980 shares during the pFebruary 6, 2024 | msn.comStrength Seen in Lifecore Biomedical (LFCR): Can Its 16.0% Jump Turn into More Strength?January 30, 2024 | finance.yahoo.comShould You Hold Lifecore Biomedical (LFCR) for Long Term?January 12, 2024 | msn.comLifecore Biomedical receives Nasdaq notice for delayed quarterly reportsJanuary 10, 2024 | finance.yahoo.comEven after rising 12% this past week, Lifecore Biomedical (NASDAQ:LFCR) shareholders are still down 39% over the past five years Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address A once-in-a-century investment opportunity (Ad)It's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead. To get its name and ticker symbol for free - just click here. LFCR Media Mentions By Week LFCR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFCR News Sentiment▼0.370.53▲Average Medical News Sentiment LFCR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFCR Articles This Week▼52▲LFCR Articles Average Week Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Acrivon Therapeutics News Today Trevi Therapeutics News Today Galectin Therapeutics News Today Rigel Pharmaceuticals News Today Omeros News Today Generation Bio News Today Ovid Therapeutics News Today Atossa Therapeutics News Today Renovaro News Today Alimera Sciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFCR) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchShocking $16T Elon Musk Crypto LeakCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlace[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
